Successful Use of Dupilumab for Recalcitrant Atopic Dermatitis in an HIV Patient

被引:10
作者
Marks, Dustin H. [1 ]
Piantadosi, Anne L. [2 ]
Patil, Sarita U. [3 ,4 ]
Raff, Adam [5 ]
Yu, JiaDe [5 ]
机构
[1] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Dept Infect Dis, Boston, MA 02115 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Dept Med, Boston, MA 02115 USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Food Allergy Ctr, Div Allergy & Immunol,Dept Pediat, Boston, MA 02115 USA
[5] Harvard Med Sch, Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02115 USA
关键词
D O I
10.1097/DER.0000000000000501
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:276 / 277
页数:2
相关论文
共 5 条
[1]  
[Anonymous], 2017, APPL NUMB 761055ORIG
[2]  
[Anonymous], 2017, Dupixent [dupilumab injection for subcutaneous use] prescribing information
[3]   Risk of infection in patients with atopic dermatitis treated with dupilumab: A meta-analysis of randomized controlled trials [J].
Fleming, Patrick ;
Drucker, Aaron M. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (01) :62-+
[4]   Allergic diseases in subjects under 18 years living with HIV [J].
Linhar, Leandro S. ;
Traebert, Jefferson ;
Galato, Dayani ;
da Silva, Rosemeri M. ;
Schuelter-Trevisol, Fabiana ;
Rovaris, Natylia S. ;
da Silva, Jane .
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2014, 10
[5]  
Marone G, 2000, CRIT REV IMMUNOL, V20, P477